Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 0.7622 | 0.756 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.1066 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0255 | 0.0255 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.0255 | 0.0255 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0146 | 0.9695 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.2678 | 0.2486 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.2678 | 0.2486 |
Brugia malayi | MH2 domain containing protein | 0.0117 | 0.7622 | 0.756 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.1556 | 0.1336 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.2063 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.1556 | 0.1336 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.2329 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.2329 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0255 | 0.0263 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.2063 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.0255 | 0.0263 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.2329 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0255 | 0.0255 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.1066 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0255 | 0.0263 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.2063 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.1066 | 0.0832 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.2329 | 0.5 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.2329 | 0.2402 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0255 | 0.0255 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.2678 | 0.2486 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.1556 | 0.1556 |
Brugia malayi | hypothetical protein | 0.0027 | 0.1066 | 0.0832 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.2329 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.1066 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0255 | 0.0255 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2678 | 0.2486 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.1066 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0255 | 0.0255 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0381 | 0.0129 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 0.7622 | 0.756 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0255 | 0.0255 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 56.2341 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.